» Authors » Wojciech Mlynarski

Wojciech Mlynarski

Explore the profile of Wojciech Mlynarski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 353
Citations 3046
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dias R, Brock K, Hu K, Gupta R, Martin U, Peet A, et al.
BMJ Open . 2025 Feb; 15(2):e091495. PMID: 40010822
Introduction: Wolfram syndrome (Spectrum Disorder) is an ultra-rare monogenic form of progressive neurodegeneration and diabetes mellitus. In common with most rare diseases, there are no therapies to slow or stop...
2.
Oszer A, Kliuchkivska K, Kolodrubiec J, Sopilnyak A, Salek M, Wlodarski M, et al.
JCO Glob Oncol . 2025 Feb; 11:e2400046. PMID: 39946670
Purpose: Soon after the Russian invasion of Ukraine in February 2022, an initiative was organized to evacuate Ukrainian children with cancer, most initially to Poland. This study assessed the impact...
3.
Urbanski B, Urbanska Z, Babol-Pokora K, Subocz E, Mlynarski W, Janczar S
Semin Thromb Hemost . 2025 Jan; PMID: 39805292
22q11.2 deletion syndrome (22q11.2DS) is one of the most common congenital malformation syndromes resulting from disrupted embryonic development of pharyngeal pouches. The classical triad of symptoms described by Angelo DiGeorge...
4.
Caye-Eude A, Fazio G, Pastorczak A, Boer J, Steinemann D, Ganguli D, et al.
Leukemia . 2024 Dec; 39(2):482-486. PMID: 39702796
No abstract available.
5.
Laguna P, Szczepanska M, Wojdalska M, Bobrowska H, Kulik J, Pietrys D, et al.
J Thromb Haemost . 2024 Nov; 23(2):635-640. PMID: 39603385
Background: Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultrarare microvascular disease caused by the deficiency of the metalloprotease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin motifs 13). Approximately half of...
6.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr . 2024 Nov; 12:1482720. PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
7.
Leszczenko P, Nowakowska A, Dawiec P, Czuja K, Jakubowska J, Zabczynska M, et al.
Analyst . 2024 Oct; 149(22):5443-5454. PMID: 39390798
Acute lymphoblastic leukaemia (ALL) is a complex disease in pediatric oncology, necessitating accurate diagnostic strategies for effective treatment planning. The ability to differentiate between B-cell ALL (B-ALL) and T-cell ALL...
8.
Mueller A, Salek M, Oszer A, Evseev D, Yakimkova T, Wlodarski M, et al.
Eur J Cancer . 2024 Sep; 210:114271. PMID: 39232428
Introduction: Coordinated medical evacuations represent an important strategy for emergency response when healthcare systems are impaired by armed conflict, particularly for patients diagnosed with life-threatening conditions such as cancer. In...
9.
Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K, et al.
Leukemia . 2024 Aug; 38(11):2344-2354. PMID: 39192035
Chromothripsis (cth) is a form of genomic instability leading to massive de novo structural chromosome rearrangements in a one-time catastrophic event. It can cause cancer-promoting alterations, such as loss of...
10.
Morawiak A, Salamonowicz-Bodzioch M, Krolak A, Kalwak K, Owoc-Lempach J, Kowalczyk J, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123368
Purpose: This study aimed to identify the risk factors for acute pancreatitis (AP) and its impact on outcomes in Polish children treated for ALL. Methods: The study group included 2303...